Ebola Vaccine Delay May Be Due To An Intellectual Property Dispute
For the past six weeks, about 800 to 1,000 doses of an experimental ebola vaccine have been sitting in a Canadian laboratory instead of being dispensed to West Africa. The delay, it would now appear, may be on account of an intellectual property spat. Back on August 13th, the Canadian government announced that it would…
